Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study
Crossref DOI link: https://doi.org/10.1007/s11102-015-0693-y
Published Online: 2015-11-24
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Caron, Philippe J.
Bevan, John S.
Petersenn, Stephan
Houchard, Aude
Sert, Caroline
Webb, Susan M.
Funding for this research was provided by:
Ipsen Fund (GB)
License valid from 2015-11-24